Piperacillin & Tazobactam for Injection USP – TAZOWELL-4.5
Piperacillin & Tazobactam for Injection USP – TAZOWELL-4.5
Description
TAZOWELL-4.5 Injection is a potent, broad-spectrum antibiotic formulation combining Piperacillin and Tazobactam, designed to effectively combat a wide range of bacterial infections, including those caused by β-lactamase producing organisms.
Composition
- Piperacillin (as Sodium) – 4 g
- Tazobactam (as Sodium) – 0.5 g
Pharmacological Action
Piperacillin works by inhibiting bacterial cell wall synthesis, leading to bacterial death. Tazobactam acts as a β-lactamase inhibitor, protecting Piperacillin from enzymatic degradation and enhancing its antibacterial spectrum.
Indications
Indicated for the treatment of moderate to severe infections such as:
- Respiratory tract infections (including pneumonia)
- Urinary tract infections (UTIs)
- Intra-abdominal infections
- Skin and soft tissue infections
- Gynecological infections
- Septicemia
- Bone and joint infections
Dosage & Administration
- For Intravenous (IV) or Intramuscular (IM) use only
- Dosage should be administered strictly under medical supervision, depending on infection severity and patient condition
Key Advantages
- Broad-spectrum antibacterial coverage
- Effective against resistant and mixed infections
- Enhanced efficacy due to β-lactamase inhibition
- Preferred choice in hospital and critical care settings
Precautions
- Use cautiously in patients with penicillin allergy
- Dose adjustment required in renal impairment
- Monitor for hypersensitivity reactions
- To be used only under qualified healthcare supervision
Storage
- Store below 25°C in a dry place
- Protect from light
Packaging
- Sterile powder vial for reconstitution





